47M.F MedMira Inc

Healthcare Biotechnology Frankfurt Exchange
0.0295 EUR
Close of Nov 11, 2026
0.0210 0.0460
Market cap
EUR 20.7M
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Apr 2026.

Is 47M.F undervalued?

Graham number

The Graham number of MedMira Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

MedMira Inc fundamental analysis

No fundamental analysis for MedMira Inc yet.

MedMira Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About MedMira Inc

MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, an…

Full company profile